在妊娠前中凝血功能和血小板参数的变化及其与怀孕结果的相关性
Juan Peng1,2,3, Quxi Zhao2,3, Wei Pang2,3
1Faculty of Environmental Science & Engineering, Kunming University of Science & Technology, Kunming City, China.
Journal of clinical hypertension (Greenwich, Conn.)
|August 26, 2024
概括
孕前 (PE) 涉及到血液凝固的改变. 这项研究发现,特定的凝血和血小板标记物,如血时间,预测PE患者的妊娠结果不佳,强调监测以改善管理.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 周围生理学 周围生理学
背景情况:
- 孕前 (PE) 是一种严重的妊娠并发症,具有显著的凝血功能障碍.
- 了解PE中凝血,血小板功能和妊娠结果之间的关系对于临床管理至关重要.
研究的目的:
- 分析患有先兆子症的患者凝血功能,血小板参数和怀孕结果之间的相关性.
- 识别特定的标记,表明PE的严重程度和相关风险.
主要方法:
- 从168名PE患者和128名健康孕妇中收集了临床数据和生物样本.
- 评估了凝血功能和血小板参数.
- 使用Kaplan-Meier和后勤回归分析来评估与PE严重程度和怀孕结果的关联.
主要成果:
- 在轻度PE中,观察到血栓激素时间 (TT) 和血小板分布宽度 (PDW) 增加,血栓激素时间 (PT) 和纤维素原减少.
- 随着PE严重程度的增加,PT,血小板计数 (PLT),平均血小板体积 (MPV),血小板克里特和凝血指数下降,而激活的部分血栓形成时间 (APTT),TT,D-二次数和PDW增加.
- 较低的PT,PLT,凝血指数或更高的APTT,TT,D-二次数和PDW与更高的不良妊娠结果风险相关. TT是一个独立的风险因素,妊娠年龄是一个保护因素.
结论:
- 特定的凝血和血小板参数与孕前的严重程度有显著的关联.
- 监测PE患者的凝血功能和血小板指数可以帮助预测和管理不良妊娠结果.
- 血栓激素时间成为预先怀孕症风险评估的关键指标.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
01:22Formation of the Platelet Plug
5.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.3K
01:33Hormonal Regulation
33.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K
01:24Disorders of Hemostasis
756
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
756
01:09Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
501
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
501